Suppr超能文献

腺苷脱氨酶缺乏所致重症联合免疫缺陷患者在T淋巴细胞去除的单倍体相合骨髓移植后T细胞和B细胞功能的重建

Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency.

作者信息

Silber G M, Winkelstein J A, Moen R C, Horowitz S D, Trigg M, Hong R

出版信息

Clin Immunol Immunopathol. 1987 Sep;44(3):317-20. doi: 10.1016/0090-1229(87)90075-4.

Abstract

A 4-month-old male received a T-lymphocyte-depleted haploidentical bone marrow transplant (BMT) for correction of severe combined immunodeficiency (SCID) due to adenosine deaminase (ADA) deficiency. Although previous haploidentical bone marrow transplants have been attempted in ADA-deficient SCID, complete reconstitution of both B-lymphocyte and T-lymphocyte function has not been obtained after a single transplant. In this patient, however, rapid, complete, and persistent engraftment occurred. Potential reasons for this successful reconstitution include the use of ablation by chemotherapy (busulfan, cyclophosphamide, and cytosine arabinoside), the in vitro technique of using monoclonal antibody (CT-2) and complement to deplete the donor cells of T lymphocytes, and the relative good health of the patient prior to the transplant. Further trials using this method of haploidentical BMT may prove it to be a successful method of immunologic reconstitution in ADA-deficient SCID patients for whom an HLA-identical marrow is not available.

摘要

一名4个月大的男性因腺苷脱氨酶(ADA)缺乏导致的重症联合免疫缺陷(SCID)接受了去除T淋巴细胞的单倍体相合骨髓移植(BMT)。尽管此前曾尝试对ADA缺乏的SCID患者进行单倍体相合骨髓移植,但单次移植后B淋巴细胞和T淋巴细胞功能均未完全重建。然而,在该患者中,出现了快速、完全且持久的植入。这种成功重建的潜在原因包括使用化疗(白消安、环磷酰胺和阿糖胞苷)进行预处理、利用单克隆抗体(CT-2)和补体在体外去除供体T淋巴细胞的技术,以及移植前患者相对良好的健康状况。使用这种单倍体相合BMT方法的进一步试验可能证明,对于无法获得HLA相合同胞骨髓的ADA缺乏的SCID患者,它是一种成功的免疫重建方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验